Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 7.1 to 5.5.
Financials
Financial year 2025
Unifarma from Kortrijk, company number BE0422674530, closed financial year 2025 with a result of € 122,718 after tax. For that financial year Unifarma recorded a gross margin of € 517,141 and equity of € 3.3 million. Compared with financial year 2024, the result moved from € -1,762 to € 122,718. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
€ 3.3 million
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 122,718
▲ still € 1,762 loss in 2024
Profit after tax over the fiscal year.
€ 191,036
▼ 29% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 164,670 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
5.5
▼ 1.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 505,497
▼ 4% vs 2024
€ 91,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 971
▼ 86% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 169,430
▼ 22% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 64,206
▼ 32% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 539,106 | € 493,412 | € 537,792 | € 517,141 | ▼ 4% |
| Profit after taxes | € -68,551 | € -64,657 | € -1,762 | € 122,718 | ▲ € 124,480 |
| Equity | € 3,576,967 | € 3,346,858 | € 3,345,095 | € 3,303,143 | ▼ 1% |
| Total debts | € 261,535 | € 309,122 | € 377,385 | € 256,116 | ▼ 32% |
| Cash | € 467,571 | € 512,524 | € 270,893 | € 191,036 | ▼ 29% |
| Land & buildings | € 3,342 | € 0 | - | - | |
| Retained profit | € 3,514,967 | € 3,284,858 | € 3,283,095 | € 3,241,143 | ▼ 1% |
| Dividend | € 0 | € 165,452 | € 0 | € 164,670 | |
| Balance sheet total | € 3,838,502 | € 3,655,979 | € 3,722,481 | € 3,559,260 | ▼ 4% |
| Employees (FTE) | 8 | 7.1 | 6.6 | 5.5 | ▼ 1.1 |
Key figures of Unifarma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Unifarma?
What happened at Unifarma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Bernadette Monballiu stepped down as director. NBB
- Thierry Van Poucke stepped down as director. NBB
- Sandrine Van Poucke stepped down as director. NBB
- Chantal Van Poucke stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 122,718. Source: NBB ↗
- Bernadette Monballiu became a director. NBB
- Thierry Van Poucke became a director. NBB
- Sandrine Van Poucke became a director. NBB
In short
From € 68,551 loss in 2022 to € 122,718 profit in 2025.
Paid € 4,074 in corporate taxes since 2022.
Best year ever: 2025, with € 122,718 profit.
On average € 94,000 of value added per employee in 2025.
A new publication or filing at Unifarma? We notify you, reason included.
Follow UnifarmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
since 2023 · until 2029
since 2023 · until 2029
since 2023 · until 2029
Chantal Van Poucke
Director
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Aalbeeksesteenweg(Kor) 58
8500 Kortrijk
Leiestraat(Kor) 27
8500 Kortrijk
Active since 1 May 1982
Deken Degryselaan(Kor) 76
8500 Kortrijk
Active since 1 May 1982
Kloosterstraat(Mar) 55
8510 Kortrijk
Active since 1 October 2015
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0422.674.530
- VAT number
- BE 0422.674.530
- Registered office
- Aalbeeksesteenweg(Kor) 58, 8500 Kortrijk
- Names & denominations
- Unifarma
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 April 1982
- Peppol
- Active · Active since 1 Sept 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten